Drug – bio-affecting and body treating compositions – In vivo diagnosis or in vivo testing
Reexamination Certificate
2005-04-12
2005-04-12
Jones, Dameron L. (Department: 1616)
Drug, bio-affecting and body treating compositions
In vivo diagnosis or in vivo testing
C424S001110, C424S001650, C424S001810, C424S001850, C435S023000, C435S024000
Reexamination Certificate
active
06878363
ABSTRACT:
A method of using radiolabelled and/or radiopharmaceutical small molecule inhibitors of beta-amyloid peptide production for the diagnosis of neurological and other disorders involving APP processing and beta-amyloid production. Radiolabelled small molecule inhibitors identified by the methods of the present invention would be useful in the diagnosis of neurological disorders, such as Alzheimer's disease, which involve elevated levels of Aβ peptides.
REFERENCES:
patent: 4666829 (1987-05-01), Glenner et al.
patent: 4859777 (1989-08-01), Toner
patent: 4988827 (1991-01-01), Bergstein et al.
patent: 5064956 (1991-11-01), Kruper, Jr.
patent: 5281704 (1994-01-01), Love et al.
patent: 5412148 (1995-05-01), Keana
patent: 5417959 (1995-05-01), Wallace
patent: 5520904 (1996-05-01), Nosco et al.
patent: 5567411 (1996-10-01), Keana et al.
patent: 5593846 (1997-01-01), Schenk et al.
patent: 5679810 (1997-10-01), Love et al.
patent: 5703129 (1997-12-01), Felsenstein et al.
patent: 5760191 (1998-06-01), Snow et al.
patent: 5801228 (1998-09-01), Hollister et al.
patent: 5804161 (1998-09-01), Long et al.
patent: 5879659 (1999-03-01), Edwards et al.
patent: 6331408 (2001-12-01), Zaczek et al.
patent: 01007734 (1984-05-01), None
patent: 0652009 (1995-05-01), None
patent: 0727225 (1996-08-01), None
patent: WO 9114460 (1991-10-01), None
patent: WO 9217215 (1992-10-01), None
patent: WO 9304194 (1993-03-01), None
patent: WO 9422496 (1994-10-01), None
patent: WO 9509838 (1995-04-01), None
patent: WO 9566934 (1995-09-01), None
patent: WO 9629313 (1996-09-01), None
patent: WO 9631243 (1996-10-01), None
patent: WO 9822430 (1998-05-01), None
patent: WO 9822433 (1998-05-01), None
patent: WO 9822441 (1998-05-01), None
patent: WO 9822493 (1998-05-01), None
patent: WO 9822494 (1998-05-01), None
patent: WO 9828268 (1998-07-01), None
patent: WO 9838177 (1998-09-01), None
patent: WO 9917717 (1999-04-01), None
patent: WO 9930815 (1999-06-01), None
patent: WO 9966934 (1999-12-01), None
patent: WO 9967219 (1999-12-01), None
patent: WO 9967220 (1999-12-01), None
patent: WO 9967221 (1999-12-01), None
patent: WO 0007995 (2000-02-01), None
patent: WO 0024392 (2000-05-01), None
patent: WO 0024967 (2000-05-01), None
patent: WO 0027666 (2000-05-01), None
patent: WO 0028331 (2000-05-01), None
patent: WO 0038618 (2000-07-01), None
patent: WO 0105236 (2001-01-01), None
patent: WO 0109703 (2001-02-01), None
patent: WO 0110297 (2001-02-01), None
patent: WO 0110667 (2001-02-01), None
patent: WO 0110773 (2001-02-01), None
patent: WO 0111714 (2001-02-01), None
patent: WO 0119797 (2001-03-01), None
patent: WO 0127104 (2001-04-01), None
patent: WO 0160826 (2001-08-01), None
patent: WO 0172324 (2001-10-01), None
patent: WO 0174783 (2001-10-01), None
patent: WO 0174784 (2001-10-01), None
patent: WO 0174796 (2001-10-01), None
patent: WO 0177086 (2001-10-01), None
Seiffer et al (Nov. 2000), Journal of Biological Chemistry, vol. 275, No. 44, pp. 34086-34091.*
Bousquet et al, Radiology 1988, 166 693-698.
Tubis and Wolf, eds Radiopharmacy, Wiley-Interscience New York (1976) vol. 1 p. 345-381(1973) table of contents.
Wilson et al. J.Org.Chem 51 4833 (1986).
U.S. Pharmacopia-The National Formulary 22ndRevision,Mack Printing Co.Easton, Pa 1990. Radioactive Pharmaceuticals relevent sections as per Index on p. 2049.
Margerstadt et al., Magn.Reson,Med. 1986,3, p 808.
Runge et al. Radiology 1988, 166 p 835.
R.Sherington et al., Nature, vol. 375 pp. 754-760,(1995).
E.I. Rogaev et al. Nature, vol. 376 pp 774-778 (1995).
T.W.Green and Wuts, Protective Groups in organic Synthesis (Wiley 1991).
A. Ahmed et al.,FEBS Letters, (1984), vol. 174, pp. 76-79.
Arora et al.,J. Med. Chem., 30: p. 918 (1987).
P. Becket, M. J. Crimmin, M. H. Davis, and Z. Spavold,Synlett(1993), pp. 137-138.
Bock et al.,J. Med. Chem. 1993, 36, pp. 4276-4292.
Bock et al.,J. Org. Chem 1987, 52, pp. 3232-3239.
M. Brechbiel and O. Gansow,Bioconjugate Chem. 1991, 2, p. 187.
M. Brechbiel and O. Gansow,J. Chem. Soc. Perkin Trans. 1992, 1, p. 1175.
M. Brinkley,Bioconjugate Chemistry 1992, 3(1), 2-13.
F. A. Carey and R. J. Sundberg, “Advanced Organic Chemistry, Part A,”New York: Plenum Press, 1990, pp. 304-305, 342-347, 475-479, 695-698.
Chumpradit et al., J. Med. Chem., 32: p. 1431 (1989).
Chumpradit et al., J. Med. Chem., 34: p. 877 (1991).
S. Deshpande et al.,J. Nucl. Med. 1990, 31, p. 473.
Eckelman et al.,J. Nucl. Med., vol. 20, pp. 350-357 (1979).
Ellis et al.,Aust. J. Chem., 26,: p. 907 (1973).
D. A. Evans et al.,Org. Synth 1990, 68, p. 83.
Glenner and Wong,Biochem. Biophys. Res. Commun. 120; pp. 885-890.
Jacobson and Reddy, Tetrahedron Letters, vol. 27, No. 46, pp. 8263-8266.
Kabalka et al.,J. Label. Compound. Radiopharm., 19: p. 795 (1992).
Koch et al. ,Chem. Ber., 124: p. 2091 (1991).
Lin et al.,PNAS(2000) 97: pp. 1456-1460.
Mach et al.,J. Med. Chem., 1993, 36, pp. 3707-3720.
McClure and Axt,Bioorganic&Medicinal Chemistry Letters, 8 (1998), pp. 143-146.
Merkushev,Synthesis, (1988), 923-927, vol. 12.
C. F. Nutaitis and M. W. Ledeboer,Org. Prep. Proced. Int. (1992), 24 (2), pp. 143-146.
Pratt et al.,Synlett, May 1998, p. 531.
M. P. Reddy and P. J. Voelker,Int. J. Pept. Protein Res. 1998, 31, pp. 345-348.
“Remington's Pharmeceutical Sciences,” 17thed. Mack Publishing Company, Easton, PA, 1985, p. 1418.
D. J. Selkoe, “Cell Biology of the amyloid (beta)-protein precursor and the mechanism of Alzheimer's disease,”Annu. Rev. Cell. Biol., 1994, 10: pp 373-403.
Severs et al.,Chem. Rev., 82, p. 575 (2982).
Sherrill et al.,J. Org. Chem. 1995, 60, pp. 730-734.
Vasser et al.,Science(1999) 286: pp. 735-741.
D. A. Walsh,Synthesis, Sep. 1980, p. 677.
Wilbur et al.,J. Label. Compound. Radiopharm., 19: p. 1171 (1982).
Eckart et al.,J. Org. Chem., 51: p. 483 (1986).
Wolf, Chrisman, Fowler, Lambrect, “Synthesis of Radiopharmaceuticals and Labeled Compounds Using Short-Lieved Isotopes,” in Radiopharmaceuticals and Labeled Compounds, vol. 1, (1973), pp. 345-381.
Olson Richard E.
Seiffert Dietmar A.
Thompson Lorin A.
Zaczek Robert
Bristol-Myers Squibb Pharma Company
Jones Dameron L.
Pillsbury & Winthrop LLP
LandOfFree
Use of small molecule radioligands to discover inhibitors of... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Use of small molecule radioligands to discover inhibitors of..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Use of small molecule radioligands to discover inhibitors of... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3440982